Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by Lumara Health, Inc.
Information provided by (Responsible Party):
Lumara Health, Inc. Identifier:
First received: June 16, 2010
Last updated: December 9, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2020
  Estimated Primary Completion Date: August 2020 (Final data collection date for primary outcome measure)